Siemens buys Bayer Diagnostics for €4.2bn

17 Jul 2006

Siemens AG has gained a competitive edge in the molecular diagnostics arena by agreeing to acquire Bayer Diagnostics for €4.2bn ($5.3bn).

In Vitro Diagnostics
In Vitro Diagnostics
- Chemistry, Immunoassay
- Hematology, Coagulation
- Molecular Diagnostics & Genetic Testing

Already a Biomedtracker subscriber? You have access to the full deal record through your subscription

Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.

Questions?

Please contact Sales at: (212) 520-2765 or email [email protected]

Related Companies

Siemens buys Bayer Diagnostics for €4.2bn

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

DCD.EmailPopout.Notice